Page 71 - Read Online

Dave et al. J Cancer Metastasis Treat 2020;6:46 I http://dx.doi.org/10.20517/2394-4722.2020.106 Page 33 of 36

173. Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules 2014;19:20091-112.
174. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem
2017;60:1620-37.
175. Priyadarsini KI. Chemical and structural features influencing the biological activity of curcumin. Curr Pharm Des 2013;19:2093-100.
176. Yang KY, Lin LC, Tseng TY, Wang SC, Tsai TH. Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by
LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2007;853:183-9.
177. Lao CD, Ruffin MT, Normolle D, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 2006;6:10.
178. Vareed SK, Kakarala M, Ruffin MT, et al. Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer
Epidemiol Biomarkers Prev 2008;17:1411-7.
179. Ireson CR, Jones DJ, Orr S, et al. Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer
Epidemiol Biomarkers Prev 2002;11:105-11.
180. Panahi Y, Fazlolahzadeh O, Atkin SL, et al. Evidence of curcumin and curcumin analogue effects in skin diseases: a narrative review. J
Cell Physiol 2019;234:1165-78.
181. Krausz AE, Adler BL, Cabral V, et al. Curcumin-encapsulated nanoparticles as innovative antimicrobial and wound healing agent.
Nanomedicine 2015;11:195-206.
182. Kang D, Li B, Luo L, et al. Curcumin shows excellent therapeutic effect on psoriasis in mouse model. Biochimie 2016;123:73-80.
183. Islam T, Koboziev I, Scoggin S, Ramalingam L, Moustaid-Moussa N. Protective effects of curcumin in high fat diet (HFD)-
induced obesity include anti-inflammatory effects in adipose tissue and changes in gut microbiome (P06-075-19). Curr Dev Nutr
2019;3:nzz031-P06.
184. Henrotin Y, Gharbi M, Dierckxsens Y, et al. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by
treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement Altern Med 2014;14:159.
185. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis.
Phytother Res 2012;26:1719-25.
186. Wu S, Xiao D. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol
2016;117:697-702.e1.
187. Ledda A, Belcaro G, Dugall M, et al. Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a
pilot, product evaluation registry study. Panminerva Med 2012;54:17-22.
188. Ide H, Tokiwa S, Sakamaki K, et al. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific
antigen. Prostate 2010;70:1127-33.
189. Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced
and metastatic breast cancer. Cancer Biol Ther 2010;9:8-14.
190. Basu P, Dutta S, Begum R, et al. Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin
containing polyherbal cream: a phase II randomized controlled study. Asian Pac J Cancer Prev 2013;14:5753-9.
191. Kanai M, Yoshimura K, Asada M, et al. A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with
gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 2011;68:157-64.
192. Dhillon N, Aggarwal BB, Newman RA, et al. Phase II trial of curcumin in patients with advanced pancreatic cancer. Clin Cancer Res
2008;14:4491-9.
193. Saberi-Karimian M, Katsiki N, Caraglia M, et al. Vascular endothelial growth factor: an important molecular target of curcumin. Crit Rev
Food Sci Nutr 2019;59:299-312.
194. Pan Z, Zhuang J, Ji C, Cai Z, Liao W, Huang Z. Curcumin inhibits hepatocellular carcinoma growth by targeting VEGF expression. Oncol
Lett 2018;15:4821-6.
195. Da W, Zhang J, Zhang R, Zhu J. Curcumin inhibits the lymphangiogenesis of gastric cancer cells by inhibiton of HMGB1/VEGF-D
signaling. Int J Immunopathol Pharmacol 2019;33:2058738419861600.
196. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent
kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 2007;6:2953-61.
197. Lee DS, Lee MK, Kim JH. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells. Anticancer Res
2009;29:5039-44.
198. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S
arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700-13.
199. Baharuddin P, Satar N, Fakiruddin KS, et al. Curcumin improves the efficacy of cisplatin by targeting cancer stem-like cells through p21
and cyclin D1-mediated tumour cell inhibition in non-small cell lung cancer cell lines. Oncol Rep 2016;35:13-25.
200. Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas
in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol
Pharmacol 2007;72:29-39.
201. Hussain AR, Al-Rasheed M, Manogaran PS, et al. Curcumin induces apoptosis via inhibition of PI3’-kinase/AKT pathway in acute T cell
leukemias. Apoptosis 2006;11:245-54.
202. Bhatia N, Zhao J, Wolf DM, Agarwal R. Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent
of milk thistle: comparison with silymarin. Cancer Lett 1999;147:77-84.
203. Gu W, Chen X, Pan X, Chan ASC, Yang TK. First enantioselective syntheses of (2R, 3R)-and (2S, 3S)-3-(4-hydroxy-3-methoxyphenyl)-
2-hydroxymethyl-1, 4-benzodioxan-6-carbaldehyde. Tetrahedron Asymmetry 2000;11:2801-7.